Here the introduction to the GMR piece
CBD watchdog Leafreport just released findings from a study revealing that 56 percent of pet products have inaccurate label claims. As is the case with products formulated for humans, this can lead to a waste of money at best and unanticipated negative health outcomes at worst. Leafreport sent 55 pet CBD products for independent testing at Canalysis Laboratories in Las Vegas. Most of the products tested were CBD oils but there were also some edibles and topical products in the mix. At Canalysis, technicians tested the products and recorded the results in certificates of analysis. Leafreport then compared the amount of CBD shown on the COAs to the advertised CBD content of each product and looked at what other cannabinoids were detected by the tests. The results suggest that despite the progress made regarding consistent quality and potency of products, there is still a ways to go.
It’s no secret that reliable testing of CBD and THC levels in products is challenging, particularly when it comes to edibles. In a recent study by Johns Hopkins, researchers discovered that only 17 percent of edibles were accurately labeled in regards to THC concentration while only one product tested with an accurate THC to CBD ratio.
Consistent with similar findings on CBD products for humans, Leafreport found that pet edibles and topicals are usually less accurate than oils and tinctures, with many companies scoring particularly poorly for their edible pet products. Furthermore, when a company claims that a product contains “full-spectrum CBD”, as many edibles marketed towards pet owners do, that means that the product should contain some level of THC (.3% or less). Despite this, 22 out of the 55 products tested by Leafreport had no THC at all. Only 44% of the tested products had CBD levels within 10% of the label, which is required for an “A” rating in the report. Some products were off as much as 98.5 percent from the label’s claim.
Read the full article